Introduction
e rst national report in the lay press on galactose-α-1,3-galactose-mediated meat allergy (or red meat allergy) appeared in the German newspaper "Der Spiegel" in December 2012 [1] . Since then, awareness of this clinical picture has increased signi cantly, not least among a ected patients, and it is not infrequent for a ected individuals to take the initiative in terms of obtaining a diagnosis. e present report uses the case of an a ected female patient as a basis to convey the fundamentals and procedures involved in a disease recognition and diagnosis that has become better understood and more readily diagnosed in recent years, as well as to emphasize the signi cance of skin tests.
Background
Following the approval of cetuximab -an antiepidermal growth factor receptor (EGFR) monoclonal antibody used in oncology -in 2006, the rst cases of anaphylaxis upon rst use of the antibody were seen in the US. Epitopes of the oligosaccharide galactose-α-1,3-galactose (α-Gal) act like an allergen on the humanized antibody cetuxi mab [2] . is oligosaccharide derives from the mouse in which this antibody was produced and has remained part of the antibody, despite "humanization", since it is spatially close to the variable binding region of EGFR. Since Old World primates and humans lost the ability to produce α-Gal themselves in the course of evolution, the oligosaccharide can have an immunogenic e ect in humans. Although it has long been known that humans can produce anti-α-Gal immunoglobulin G (IgG) antibodies in large quantities, the discovery of α-Gal-speci c IgE in 2008 was completely new [2] . It was shown as early as in 2009 that anti-α-Gal IgE antibodies can elicit anaphylaxis not only to portions of cetuximab derived from non-primate mammals, but also upon red meat consumption. In this context, symptom onset is comparatively delayed (3-8 h following consumption) and may manifest as urticaria, angioedema or anaphylaxis [3] . Tick bites, which are particularly endemic in the area where cetuximab-induced anaphylaxis and delayed red meat allergy occurred, are suspected to be the trigger of sensitization. e Spiegel article described this development and referred to the rst α-Gal patients identi ed in Germany [1, 4] .
Case report
In the weeks following the appearance of the article, Spiegel readers contacted the Department of Dermatology at the Tübingen University Hospital under the assumption that they were a ected by the allergy cited in the Spiegel report and subsequently presented for diagnosis. [2, 3, 5] . ImmunoCAP measured speci c IgE for α-Gal of 0.12 kU/l and for beef of 0.14 kU/l with a total IgE of 10.4 kU/l. Other meatrelated IgE measurements (pork, lactoprotein and cat dander) were undetectable at < 0.1 kU/l. No reaction was seen in skin prick testing with commercially available skin prick test solutions for meat (beef, pork, horse, lamb). Prick-to-prick testing with fresh samples of porcine kidney, pork, bovine kidney and beef showed a one-fold positive reaction with porcine kidney and a questionable reaction with bovine kidney. Intracutaneous testing with gelatin polysuccinate (Gelafundin®) showed no reaction. Animal gelatin also contains α-Gal and can elicit anaphylaxis through exposure to Gelafundin [6] , as well as following extensive consumption of gelatin-containing sweets such as jelly babies [7] . us, Gelafundin can yield evidence of sensitization in skin testing. It was not possible to repeat the in-tracutaneous test that had led to the diagnosis of meat allergy in 2006, since the intracutaneous test solution were originally used was no longer available in Germany in 2013.
Discussion
On the basis of the patient's history and ndings, this disease could be classi ed as α-Gal-mediated meat allergy. It is apparent in retrospect that the allergists dealing with this patient's case back in 2006 had done a remarkable job with their diagnosis of "immediate-type allergy to meat from Artiodactyla" and had been ahead of their time. is case report illustrates how the availability of diagnostic tests in uences the diagnostic process. Where an important allergen is already known and available for the serological measurement of speci c IgE, or even available as a single allergen, the physician with less experience of allergies can also investigate suspected sensitization in a targeted manner. If, however, the triggering allergen is unknown, the problem needs to be narrowed down by systematically excluding possible allergens. Skin prick and intracutaneous tests in particular have proved to be helpful here in the past. e present case report is a striking example of how skin tests in the hands of experienced allergists make it possible, despite unknown allergens, to detect the problem area e ectively and provide appropriate dietary guidance. Test sensitivity is a critical factor here. Commercial skin prick test solutions for meats are not diagnostically reliable for α-Gal-mediated red meat allergy [3, 8] . It can be conjectured that the concentration of α-Gal in these solutions is too low. As own studies as well as US studies show, intracutaneous tests can be very sensitive in α-Gal-mediated red meat allergy and are hence the diagnostic method of choice [6, 8] . Unfortunately, the intracutaneous test solutions described above for various meats have not been available in Germany since 2007. Presumably, increased quality requirements stipulated by the Paul-Ehrlich Institute resulted in the withdrawal of intracutaneous solutions from the market. It is possible that the supplier may have decided di erently a year later -a er the α-Gal allergen was described for the rst time. For the time being, in the case of strong suspicion, there is no choice but to resort to prick-to-prick testing with fresh meat samples, for which personnel requirements are higher, or intracutaneous testing with gelatin-containing infusion solutions [6, 8] . Due to the need to produce tests individually, this forced practice means greater logistical e ort for patients and physicians and reduced availability of diagnostic measures. Moreover, these individually produced tests are not able to achieve the same quality and reproducibility of the intracutaneous tests withdrawn for quality reasons since, according to the German Medicines Act, they are always considered a diagnostic investigation in the "isolated case". us, adequate standardization is not possible. e discontinuation of intracutaneous testing with meat solutions is therefore a loss in quality and a step backwards in allergy patient care.
is gap cannot be fully compensated for by the now CE-certi ed assay-detecting speci c IgE α-Gal for the existing routine diagnosis (α-Gal-rich bovine thyroglobulin as a substrate). Our case report documents how the biological relevance of speci c IgE to α-Gal of 0.12 kU/l only became evident as a result of the clinical course and the patient's extremely low total IgE, since the measured titre was close to the 0.1-kU/l cut-o , meaning that here again in vitro serum tests alone would not have yielded the diagnosis. In the context of the greater awareness of this new form of allergy to an oligosaccharide, other clinical phenotypes of meat allergy have now been found. e triggering allergen and its characteristics are as yet unknown or only partially identi ed [9] . Although this clinical picture is of great interest from both a scienti c and a clinical point of view, we are in a poorer position in Germany in 2015 in terms of diagnosing meat allergy using skin tests than we were in 2006.
